Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID-19.


Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
04 2021
Historique:
received: 20 01 2021
revised: 27 01 2021
accepted: 28 01 2021
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 26 3 2021
Statut: ppublish

Résumé

Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb

Identifiants

pubmed: 33710753
doi: 10.1002/prp2.743
pmc: PMC7953359
doi:

Substances chimiques

Furans 0
Pyrroles 0
Triazines 0
GS-441524 1BQK176DT6
remdesivir 3QKI37EEHE
Adenosine Monophosphate 415SHH325A
Adenosine K72T3FS567
Alanine OF5P57N2ZX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00743

Informations de copyright

© 2021 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.

Références

Drugs R D. 2020 Sep;20(3):217-223
pubmed: 32415538
Blood Purif. 2002;20(4):380-8
pubmed: 12169849
Intensive Care Med. 2019 Feb;45(2):236-239
pubmed: 30446798
Crit Care. 2020 Jul 14;24(1):435
pubmed: 32664996
Clin Transl Sci. 2020 Sep;13(5):896-906
pubmed: 32589775
Pharmacol Res Perspect. 2021 Feb;9(1):e00705
pubmed: 33421347
Intensive Care Med Exp. 2020 Jun 15;8(1):21
pubmed: 32542550
Cell Rep. 2020 Jul 21;32(3):107940
pubmed: 32668216
JACC Basic Transl Sci. 2017 Apr 24;2(2):135-145
pubmed: 30167561
Clin Chem Lab Med. 2020 Jun 22;58(9):1461-1468
pubmed: 32573468
Int J Cardiol. 2019 Oct 15;293:73-75
pubmed: 31296393
Blood Purif. 2018;45(1-3):126-128
pubmed: 29402788

Auteurs

Paul Biever (P)

Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine II (Division of Infectious Diseases), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Dawid L Staudacher (DL)

Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Michaela J Sommer (MJ)

Institute of Forensic Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Hermann Staudinger Graduate School, University of Freiburg, Freiburg, Germany.

Hannah Triebel (H)

Institute of Forensic Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Merja A Neukamm (MA)

Institute of Forensic Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Christoph Bode (C)

Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Alexander Supady (A)

Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Achim Lother (A)

Heart Center Freiburg University, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH